TALVEY sol inj 3 mg/1.5ml flac 1.5 ml
7680690490010
CH-69049
L01FX
07.16.1.
Reimbursement limitations:
TALVEY.01
Après garantie de prise en charge par l’assureur-maladie après consultation préalable du médecin-conseil.
TALVEY est …
1 / 3
google
Details
- Product number
- 6904901
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- talquetamabum 3 mg, natrii acetas ut natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 20, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium 0.38 mg.
Articles (1)
Talvey 3 mg/1.5 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
3.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.38 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 368.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2024
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69049
- Drug name
- Talvey, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01FX29
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 30/10/2023
- Authorization expiration date
- 31/12/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TALVEY sol inj 3 mg/1.5ml flac 1.5 ml
- Description (DE)
- TALVEY Inj Lös 3 mg/1.5ml Durchstf 1.5 ml
- Market launch
- 30/10/2023
- Narcotic (BTM)
- No